SB 239

  • Alabama Senate Bill
  • 2023 Regular Session
  • Introduced in Senate Apr 25, 2023
  • Passed Senate May 03, 2023
  • Passed House May 18, 2023
  • Became Law Jun 01, 2023

Relating to Opioid Addiction Treatment; to repeal the Medication Assisted Treatment of Opioid Use Act of 2019, codified as Sections 20-2-300 through 20-2-302, Code of Alabama 1975, that provide for adoption of rules governing use of buprenorphine in the treatment of opioid addiction and a standing working group to assist in drafting the rules.

Abstract

Medication Assisted Treatment of Opioid Use Act, repealed

Bill Sponsors (1)

Votes


Actions


Jun 01, 2023

Office of the Governor

Enacted as 2023-339

May 18, 2023

House

Ready to Enroll

House

Read a Third Time and Pass

House

On Third Reading in Second House

Senate

Enrolled

May 11, 2023

House

Read Second Time in Second House

May 10, 2023

House

Reported Favorably (Health)

House

Reported Out of Committee in Second House

May 04, 2023

Senate

Read First Time in Second House

House

Referred to Committee (Health)

May 03, 2023

Senate

Read a Third Time and Pass

Senate

On Third Reading in House of Origin

Senate

Read a Third Time and Pass

Apr 27, 2023

Senate

Read Second Time in House of Origin

Apr 26, 2023

Senate

Reported Out of Committee in House of Origin

Senate

Reported Favorably (Healthcare)

Apr 25, 2023

Senate

Introduced and Referred (Healthcare)

Senate

Read First Time in House of Origin

Bill Text

Bill Text Versions Format
Introduced PDF
Enrolled PDF
Act 2023-339 PDF

Related Documents

Document Format
Fiscal Note: As Introduced PDF
Fiscal Note: As Passed First Chamber PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Alabama Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.